Anomaly Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 18

Anomaly General Information

Description

Developer of a protein engineering platform designed to discover new protein-based medicines for complex diseases. The company offers computational protein design, AI-based discovery methods and laboratory technologies for creating and testing therapeutic proteins to replace fragile, extraction-based supply chains with scalable, on-demand, and globally resilient biomanufacturing, enabling biopharmaceutical researchers to create new treatments with improved biological properties for patients with difficult-to-treat diseases.

Contact Information

Website
www.anomalybio.com
Formerly Known As
Pawsible Foods
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Singapore
  • Singapore
Primary Industry
Biotechnology
Other Industries
Personal Products
Vertical(s)
Advanced Manufacturing, AgTech, Life Sciences
Corporate Office
  • Singapore
  • Singapore

Anomaly Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anomaly Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Accelerator/Incubator 27-Aug-2026 Completed Startup
9. Seed Round 12-Nov-2025 Completed Startup
8. Grant 03-May-2025 Completed Startup
7. Accelerator/Incubator 05-Sep-2024 Completed Startup
6. Grant 01-Jan-2023 Completed Startup
5. Accelerator/Incubator 01-Jan-2022 Completed Startup
4. Grant 01-Jan-2022 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Anomaly’s complete valuation and funding history, request access »

Anomaly Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Anomaly’s complete cap table history, request access »

Anomaly Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anomaly Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
ProVeg Incubator Accelerator/Incubator
Angel (individual) Minority
Angel (individual) Minority
Indian Silicon Valley Angel Group Minority
Angel (individual) Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Anomaly FAQs

  • When was Anomaly founded?

    Anomaly was founded in 2022.

  • Where is Anomaly headquartered?

    Anomaly is headquartered in Singapore, Singapore.

  • What is the size of Anomaly?

    Anomaly has 5 total employees.

  • What industry is Anomaly in?

    Anomaly’s primary industry is Biotechnology.

  • Is Anomaly a private or public company?

    Anomaly is a Private company.

  • What is Anomaly’s current revenue?

    The current revenue for Anomaly is .

  • How much funding has Anomaly raised over time?

    Anomaly has raised $2.62M.

  • Who are Anomaly’s investors?

    ProVeg Incubator, , , Indian Silicon Valley, and are 5 of 18 investors who have invested in Anomaly.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process